AIMS/HYPOTHESIS: While it is well known that diet-induced obesity causes insulin resistance, the precise mechanisms underpinning the initiation of insulin resistance are unclear. To determine factors that may cause insulin resistance, we have performed a detailed time-course study in mice fed a high-fat diet (HFD). METHODS: C57Bl/6 mice were fed chow or an HFD from 3 days to 16 weeks and glucose tolerance and tissue-specific insulin action were determined. Tissue lipid profiles were analysed by mass spectrometry and inflammatory markers were measured in adipose tissue, liver and skeletal muscle. RESULTS: Glucose intolerance developed within 3 days of the HFD and did not deteriorate further in the period to 12 weeks. Whole-body insulin resistance, measured by hyperinsulinaemic-euglycaemic clamp, was detected after 1 week of HFD and was due to hepatic insulin resistance. Adipose tissue was insulin resistant after 1 week, while skeletal muscle displayed insulin resistance at 3 weeks, coinciding with a defect in glucose disposal. Interestingly, no further deterioration in insulin sensitivity was observed in any tissue after this initial defect. Diacylglycerol content was increased in liver and muscle when insulin resistance first developed, while the onset of insulin resistance in adipose tissue was associated with increases in ceramide and sphingomyelin. Adipose tissue inflammation was only detected at 16 weeks of HFD and did not correlate with the induction of insulin resistance. CONCLUSIONS/ INTERPRETATION: HFD-induced whole-body insulin resistance is initiated by impaired hepatic insulin action and exacerbated by skeletal muscle insulin resistance and is associated with the accumulation of specific bioactive lipid species.
AIMS/HYPOTHESIS: While it is well known that diet-induced obesity causes insulin resistance, the precise mechanisms underpinning the initiation of insulin resistance are unclear. To determine factors that may cause insulin resistance, we have performed a detailed time-course study in mice fed a high-fat diet (HFD). METHODS: C57Bl/6 mice were fed chow or an HFD from 3 days to 16 weeks and glucose tolerance and tissue-specific insulin action were determined. Tissue lipid profiles were analysed by mass spectrometry and inflammatory markers were measured in adipose tissue, liver and skeletal muscle. RESULTS:Glucose intolerance developed within 3 days of the HFD and did not deteriorate further in the period to 12 weeks. Whole-body insulin resistance, measured by hyperinsulinaemic-euglycaemic clamp, was detected after 1 week of HFD and was due to hepatic insulin resistance. Adipose tissue was insulin resistant after 1 week, while skeletal muscle displayed insulin resistance at 3 weeks, coinciding with a defect in glucose disposal. Interestingly, no further deterioration in insulin sensitivity was observed in any tissue after this initial defect. Diacylglycerol content was increased in liver and muscle when insulin resistance first developed, while the onset of insulin resistance in adipose tissue was associated with increases in ceramide and sphingomyelin. Adipose tissue inflammation was only detected at 16 weeks of HFD and did not correlate with the induction of insulin resistance. CONCLUSIONS/ INTERPRETATION: HFD-induced whole-body insulin resistance is initiated by impaired hepatic insulin action and exacerbated by skeletal muscle insulin resistance and is associated with the accumulation of specific bioactive lipid species.
Authors: Faidon Magkos; Xiong Su; David Bradley; Elisa Fabbrini; Caterina Conte; J Christopher Eagon; J Esteban Varela; Elizabeth M Brunt; Bruce W Patterson; Samuel Klein Journal: Gastroenterology Date: 2012-03-13 Impact factor: 22.682
Authors: Simon M Chalkley; Manthinda Hettiarachchi; Donald J Chisholm; Edward W Kraegen Journal: Am J Physiol Endocrinol Metab Date: 2002-06 Impact factor: 4.310
Authors: A U Błachnio-Zabielska; M Pułka; M Baranowski; A Nikołajuk; P Zabielski; M Górska; J Górski Journal: J Cell Physiol Date: 2012-02 Impact factor: 6.384
Authors: Katie Colbert Coate; Melanie Scott; Ben Farmer; Mary Courtney Moore; Marta Smith; Joshua Roop; Doss W Neal; Phil Williams; Alan D Cherrington Journal: Am J Physiol Endocrinol Metab Date: 2010-09-07 Impact factor: 4.310
Authors: John R Ussher; Timothy R Koves; Virgilio J J Cadete; Liyan Zhang; Jagdip S Jaswal; Suzanne J Swyrd; David G Lopaschuk; Spencer D Proctor; Wendy Keung; Deborah M Muoio; Gary D Lopaschuk Journal: Diabetes Date: 2010-06-03 Impact factor: 9.461
Authors: Nigel Turner; Krit Hariharan; Jennifer TidAng; Georgia Frangioudakis; Susan M Beale; Lauren E Wright; Xiao Yi Zeng; Simon J Leslie; Jing-Ya Li; Edward W Kraegen; Gregory J Cooney; Ji-Ming Ye Journal: Diabetes Date: 2009-08-31 Impact factor: 9.461
Authors: Troy L Campbell; Andrew S Mitchell; Elliott M McMillan; Darin Bloemberg; Dmytro Pavlov; Isabelle Messa; John G Mielke; Joe Quadrilatero Journal: Exp Biol Med (Maywood) Date: 2014-10-30
Authors: Michael A Hendley; Kendall P Murphy; Christopher Isely; Heather L Struckman; Prakasam Annamalai; R Michael Gower Journal: Biomaterials Date: 2019-06-19 Impact factor: 12.479
Authors: Roland Stocker; David E James; Daniel J Fazakerley; Rima Chaudhuri; Pengyi Yang; Ghassan J Maghzal; Kristen C Thomas; James R Krycer; Sean J Humphrey; Benjamin L Parker; Kelsey H Fisher-Wellman; Christopher C Meoli; Nolan J Hoffman; Ciana Diskin; James G Burchfield; Mark J Cowley; Warren Kaplan; Zora Modrusan; Ganesh Kolumam; Jean Yh Yang; Daniel L Chen; Dorit Samocha-Bonet; Jerry R Greenfield; Kyle L Hoehn Journal: Elife Date: 2018-02-06 Impact factor: 8.140
Authors: M Balakumar; L Raji; D Prabhu; C Sathishkumar; P Prabu; V Mohan; M Balasubramanyam Journal: Mol Cell Biochem Date: 2016-10-03 Impact factor: 3.396